Myocarditis Induced By Immune Checkpoint Inhibitor Nivolumab Myocarditis Induced By Immune Checkpoint Inhibitor Nivolumab

This case illustrates myocarditis as a severe and potentially fatal cardiovascular complication of therapy with an immune checkpoint inhibitor.Journal of Medical Case Reports
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Family Medicine/Primary Care Journal Article Source Type: news